|
PARP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.85784762310959E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45309999588505E-08 |
| Normal-vs-Stage2 |
4.750700E-04 |
| Normal-vs-Stage3 |
1.368780E-04 |
| Normal-vs-Stage4 |
1.050610E-01 |
| Stage1-vs-Stage2 |
9.236300E-02 |
| Stage1-vs-Stage3 |
3.372400E-01 |
| Stage1-vs-Stage4 |
6.485600E-01 |
| Stage2-vs-Stage3 |
5.077600E-01 |
| Stage2-vs-Stage4 |
7.547400E-01 |
| Stage3-vs-Stage4 |
9.326600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.92960100622963E-11 |
| Normal-vs-AfricanAmerican |
1.57469999995108E-06 |
| Normal-vs-Asian |
5.499700E-02 |
| Caucasian-vs-AfricanAmerican |
8.628600E-01 |
| Caucasian-vs-Asian |
6.916200E-01 |
| AfricanAmerican-vs-Asian |
6.275400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.79358783170392E-12 |
| Normal-vs-Female |
1.28820000000474E-07 |
| Male-vs-Female |
9.040000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.879200E-03 |
| Normal-vs-Extreme_Weight |
7.83479999988401E-07 |
| Normal-vs-Obese |
1.38569999919014E-08 |
| Normal-vs-Extreme_Obese |
1.408160E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.279000E-01 |
| Normal_Weight-vs-Obese |
5.775800E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.444000E-01 |
| Extreme_Weight-vs-Obese |
3.581700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.336600E-01 |
| Obese-vs-Extreme_Obese |
2.176200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.40569999999662E-05 |
| Normal-vs-Age(41-60Yrs) |
3.41349171151251E-12 |
| Normal-vs-Age(61-80Yrs) |
3.17139999816973E-08 |
| Normal-vs-Age(81-100Yrs) |
2.272800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.865600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.172400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.419340E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.937730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.217130E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.660400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.43447492667792E-12 |
| Normal-VS-Type2 PRCC |
7.642400E-04 |
| Normal-VS-KIRP CIMP |
6.562200E-03 |
| Normal-VS-Unclassified PRCC |
1.67468999999754E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.703700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.362300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.635900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.021800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.438800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.443600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.380370E-04 |
| Normal-vs-N1 |
2.566500E-04 |
| Normal-vs-N2 |
4.495400E-01 |
| N0-vs-N1 |
5.076400E-02 |
| N0-vs-N2 |
7.127000E-01 |
| N1-vs-N2 |
9.083600E-01 |
|
|
